
Our founders Kirsty and Tom McCarthy are driven by a shared passion: Operationalising exceptional science into successful business.
Following the 2015 acquisition of Spinifex Pharmaceuticals by Novartis, they founded MTM, a biotechnology ecosystem company specialising in biotech venture creation and integrated support services.
Today we empower biotech ventures to achieve scientific, clinical, and commercial excellence through our discovery and development ecosystem.